Placebo-Controlled Study of Risperidone for the Treatment of Children and Adolescents With Autism and Negative Behavioral Symptoms.
Phase of Trial: Phase III
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Risperidone (Primary)
- Indications Autistic disorder; Behavioural disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms RUPP
- 15 Feb 2007 Status changed from in progress to completed.
- 15 Oct 2005 New trial record.